Agios to Webcast Conference Call of Third Quarter 2019 Financial Results on October 31, 2019
October 17 2019 - 7:00AM
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field
of cellular metabolism to treat cancer and rare genetic diseases,
today announced that the company will host a conference call and
live webcast on Thursday, October 31, 2019 at 8:00 a.m. ET to
report its third quarter 2019 financial results and other business
highlights.
A live webcast can be accessed under "Events
& Presentations" in the Investors section of the company's
website at www.agios.com. The conference call can be accessed by
dialing 1-877-377-7098 (domestic) or 1-631-291-4547 (international)
and referring to conference ID 5996044. The webcast will be
archived and made available for replay on the company's website
beginning approximately two hours after the event.
About AgiosAgios is focused on
discovering and developing novel investigational medicines to treat
cancer and rare genetic diseases through scientific leadership in
the field of cellular metabolism and adjacent areas of biology. In
addition to an active research and discovery pipeline across both
therapeutic areas, Agios has two approved oncology precision
medicines and multiple first-in-class investigational therapies in
clinical and/or preclinical development. All Agios programs focus
on genetically identified patient populations, leveraging our
knowledge of metabolism, biology and genomics. For more
information, please visit the company's website at
www.agios.com.
Investor & Media
Contact:Holly Manning, 617-844-6630Associate Director,
Investor RelationsHolly.Manning@agios.com
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Sep 2023 to Sep 2024